Affective neuroscience in psychiatry may offer a better way to understand patients who do not fit neatly into DSM categories. Dr. White joins us to explain Jaak Panksepp’s seven primary emotional systems, the difference between affect and emotion, and how subcortical emotional arousal interacts with cortical regulation. We discuss anger, borderline personality disorder, cognitive decline, mindfulness, ACT, emotional blunting with SSRIs, and why some cases labeled treatment-resistant depression may need a better formulation rather than another medication. We also get into the neuroscience behind the model… from decortication and brain-stimulation studies to TMS… and ask what psychiatry loses when diagnosis comes before understanding affect.Dr. White’s Substack:
What we cover
* The case from animal neuroscience that conserved subcortical circuits drive emotional behavior in mammals, Jaak Panksepp's work, and why Dr. White thinks the DSM largely leaves affect out (the push for reliable checklists around DSM-III).
* Affect versus emotion: affect as raw subcortical arousal, emotion as affect shaped by cortical appraisal, memory, culture and narrative, and how Dr. White draws a brainstem, midbrain and cortex for patients.
* Panksepp's seven primary systems, including the negative-valence fear, rage and panic-grief (separation distress), and a proposed set of four dimensions for each system: baseline activity, reactivity, recovery time and threshold.
* Clinical uses: patients with intense anger who do not fit a DSM box, borderline personality as arousal outrunning cortical capacity, DBT as building that capacity, and late-life anxiety or distress when cortical regulation declines.
* Medication management and short visits: describing medications as changing emotions broadly, asking about emotional blunting, adding mindfulness and acceptance-based skills, and why bottom-up intensity is not yet treatable.
* Evidence and implications: decortication in cats, children born without a cortex, cortical versus deep brain stimulation, TMS to the DLPFC as top-down input, aprepitant trials in depression, and doubts about treatment-resistant depression labels.
Clinical takeaways
* When a patient has intense anger or big feelings without the full borderline picture, consider formulating it as strong arousal that outpaces regulation. Dr. White finds this less invalidating than a fixed personality label.
* A simple drawing helps: feelings come up from below without planning, and the aim is to build the capacity to observe a feeling and delay a response; the feeling itself stays.
* In older patients with new anxiety or depression and no history, check cognition (Dr. White uses the MoCA). Declining cortical regulation may explain reactions such as distress at separation.
* Counsel that a medication may change emotional intensity broadly, and ask about emotional blunting, which patients prone to intense feelings tend to notice.
* Before calling depression treatment resistant, Dr. White reformulates and asks what would change in the patient's life if they felt better, checking sleep, activity, exercise and connection.
* Pair medication with brief skills and a referral for real psychotherapy. He argues that treatments strengthen top-down control and that evidence for lowering bottom-up intensity is lacking.
Read the full transcript
The complete transcript of this episode is on psycho.farm: Affective Neuroscience: Understanding Patients Beyond DSM Diagnoses.
Related episodes
* What Psychiatrists Get Wrong About Personality Disorders
* Understanding Borderline Personality Disorder with Dr. Mark L. Ruffalo
For education only. Not medical advice.